Email ID
Password
Forgotten your password?
Sign me in automatically next time
Advanced Search
Home
Companies
Patients
Investigators
Trials & Research
Regulatory
Therapeutics
News
Features
Commentary
People
Events
White Papers
HOME - NEWS
Filter By:
2012
2011
2010
2009
2008
Parexel and ASAN form Korean alliance
02 February 2012
The CRO Parexel International is upping its game in Asia, by forming an alliance with the Seoul-based ASAN Medical Center (AMC). The collaboration with the South Korean AMC, the parent of seven hospitals which are part of the Asan Foundation established in 1977, will focus primarily on early phase ...
PPD and VirtualScopics expand strategic alliance for medical imaging services
27 January 2012
PPD and VirtualScopics have expanded their one-year strategic alliance in clinical and medical imaging services across multiple therapeutic areas to now include oncology, central nervous system, cardiovascular, general medicine and medical devices. The companies deliver integrated and customised ...
Ergomed partners Hikma for oncology trials in Jordan
26 January 2012
Hikma Pharmaceuticals is to partner with the German full-service CRO Ergomed , which will manage clinical trials of Hikma oncology treatments in a pilot project in Jordan. Ergomed will be conducting the first clinical trials for one of Hikma’s key oncology products in Jordanian hospitals, with ...
Parexel extends early-phase network with UK hospital collaboration
24 January 2012
Parexel International has established an alliance with University Hospitals Bristol National Health Service (NHS) Foundation Trust (UH Bristol), one of the largest specialist teaching and research hospital trusts in the United Kingdom, to expand its early-phase alliance network. The CRO's alliance ...
Lilly exit from JV with Jubilant doesn't end commitment to FIPNet strategy
24 January 2012
Lilly and the Jubilant group have exited their equally owned Indian joint venture for early stage drug development, Vanthys, though the US multinational suggests that the decision is in no way indicative of any departure from its fully integrated pharmaceutical network strategic approach to capture ...
Quintiles invests in biomarker start-up; Glyn Edwards to head
20 January 2012
Quintiles has invested £3 million in a new company formed in partnership with the University of Oxford and two of its professors, which will provide oncology consulting services and new cancer biomarkers to clients. Glyn Edwards , the ex-CEO of Antisoma and the interim CEO of the BioIndustry ...
Quintiles opens Chinese BPO centre
18 January 2012
Quintiles has opened a business process outsourcing (BPO) and project management centre of excellence in Dalian, northeast China, to serve the Japanese, Chinese and South Korean biopharmaceutical markets. The Dalian office will provide data management, biostatistics, medical writing, ...
CROs: pharma partners or rival, asks report?
18 January 2012
Contract research organisations (CRO) are gaining the right skills to become direct competitors to their clients, the pharmaceutical and biotechnology business, as the level of drug discovery and development outsourcing increases in the future. This was the sentiment expressed by 45% of those ...
Greenphire and Merge partner to integrate technology platforms
17 January 2012
Greenphire , a technology company that offers web-based clinical payment technology platforms to research sites, and the clinical trials division of Merge Healthcare, a provider of clinical trial technology solutions, have formed an exclusive partnership to offer integrated functionality between ...
GSK disputes Argentine fine over baby vaccination scandal
12 January 2012
GlaxoSmithKline is set to appeal a ruling by the Supreme Court of Argentine on the fine it was issued regarding the administrative conduct of the COMPAS (Clinical Otitis Media and PneumoniA Study) study in Mendoza. GSK said it "respectfully disagrees" with the decision, which ruled in favour of ...
Covance collaborates with French research institute
12 January 2012
Covance , the French National Institute of Health and Medical Research subsidiary Inserm Transfert , and the seed investment company Inserm Transfert Initiative have signed a four-year scientific collaboration agreement for research and development. Under terms of the agreement, Covance will ...
ShangPharma opens new facility to support Lilly's expanding pipeline
11 January 2012
The Chinese CRO ShangPharma has opened a new facility to meet the growing capacity needs of Lilly , which is one of the company's largest customers. ShangPharma's newly opened facility adds 110,000 square feet of laboratory and office space to the company's overall capacity, and is fully dedicated ...
Shire selects ICON and PRA for clinical development partnership
10 January 2012
The specialty pharmaceuticals division of Shire has chosen two CROs as strategic partners for its clinical development programmes. One is the Dublin-based CRO ICON and the other, although unnamed by Shire, is thought to be PRA. In addition, ICON will now be the sole global provider of central ...
Pfizer collaborates for Phase III axitinib Asia trial
10 January 2012
Pfizer has inked a deal with SFJ Pharma Ltd II , a drug development company that specialises in obtaining regulatory approval for drugs for the Japanese market, to conduct a Phase III clinical study for the investigational agent axitinib in six Asian countries. SFJ will provide the funding and ...
Clinical trial reporting still dangerously inadequate, says BMJ
05 January 2012
The British Medical Journal (BMJ) has published seven research papers providing a damning indictment of current practice in clinical trial reporting. According to the accompanying editorial by senior research fellow Richard Lehman and clinical epidemiology editor Elizabeth Loder , the articles ...
Page 1(of 2)
1.
2 .
Next »
MOST MENTIONED
COMPANY/ORGANISATION
PFIZER
PPD
ANTISOMA
BRISTOL-MYERS SQUIBB
CONDITION
CANCER
DIAGNOSTIC
OTITIS
GEOGRAPHY
INDIA
UNITED KINGDOM
ARGENTINA
BRAZIL
DRUG
AXITINIB
ELESCLOMOL
STA-9090
About Us
Getting Started
Subscribe
FREE Trial
Advertise
Awards
White Papers
EVENTS
Partnerships in Clinical Trials
04 March 2012
The Marriott World Center, Orlando, Florida
